[go: up one dir, main page]

EE03384B1 - Use of melatonin for the manufacture of a medicament - Google Patents

Use of melatonin for the manufacture of a medicament

Info

Publication number
EE03384B1
EE03384B1 EE9700166A EE9700166A EE03384B1 EE 03384 B1 EE03384 B1 EE 03384B1 EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A EE 03384 B1 EE03384 B1 EE 03384B1
Authority
EE
Estonia
Prior art keywords
melatonin
medicament
manufacture
Prior art date
Application number
EE9700166A
Other languages
Estonian (et)
Other versions
EE9700166A (en
Inventor
Zisapel Nava
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of EE9700166A publication Critical patent/EE9700166A/en
Publication of EE03384B1 publication Critical patent/EE03384B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9700166A 1995-02-01 1996-01-29 Use of melatonin for the manufacture of a medicament EE03384B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
EE9700166A EE9700166A (en) 1998-02-16
EE03384B1 true EE03384B1 (en) 2001-04-16

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700166A EE03384B1 (en) 1995-02-01 1996-01-29 Use of melatonin for the manufacture of a medicament

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782266B2 (en) 2000-01-05 2005-07-14 Neurim Pharmaceuticals (1991) Ltd. Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
US8785492B2 (en) 2012-01-26 2014-07-22 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
AU2013361459A1 (en) 2012-12-18 2015-07-02 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
RS61024B1 (en) * 2016-10-31 2020-12-31 Neurim Pharma 1991 Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134789T3 (en) * 1991-05-09 1999-10-16 Neurim Pharma 1991 COMPOSITIONS CONTAINING MELATONIN.
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
DK89697A (en) 1997-07-30
NO973531D0 (en) 1997-07-31
WO1996023496A1 (en) 1996-08-08
FI973185A0 (en) 1997-07-31
BG101803A (en) 1998-04-30
SK284521B6 (en) 2005-05-05
LV11940A (en) 1998-01-20
TR199700723T1 (en) 1998-02-21
LU90118B1 (en) 1997-11-13
JP4516159B2 (en) 2010-08-04
NO973531L (en) 1997-09-30
AU4457496A (en) 1996-08-21
ATA901396A (en) 2001-02-15
PL321630A1 (en) 1997-12-08
NZ298878A (en) 1999-05-28
PL183148B1 (en) 2002-05-31
LV11940B (en) 1998-05-20
JPH10513177A (en) 1998-12-15
MD970254A (en) 1999-05-31
DK176081B1 (en) 2006-04-18
CZ291349B6 (en) 2003-02-12
IS1980B (en) 2005-01-14
MX9705856A (en) 1998-07-31
FI119586B (en) 2009-01-15
FI973185L (en) 1997-09-30
BR9607169A (en) 1997-11-11
BG62876B1 (en) 2000-10-31
AU695366B2 (en) 1998-08-13
EE9700166A (en) 1998-02-16
CZ240597A3 (en) 1998-01-14
TW483757B (en) 2002-04-21
SI9620022A (en) 1998-10-31
MD1716B2 (en) 2001-08-31
IS4532A (en) 1997-07-25
NO312814B1 (en) 2002-07-08
MD1716C2 (en) 2002-02-28
AT408188B (en) 2001-09-25
CN1083263C (en) 2002-04-24
CN1172431A (en) 1998-02-04
SK103097A3 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
NO20040145L (en) Use of benzenesulfonamide derivatives for the manufacture of a medicament
FI971279L (en) Drug
ATE192157T1 (en) THERAPEUTIC SPIRO-AZABICYCLIC COMPOUNDS
IS4662A (en) inhaler
DK0769017T3 (en) Therapeutic compounds
FI973243L (en) New pharmaceutical combination
ATE213142T1 (en) NASAL DILATATOR
CY2013020I1 (en) THE USE OF AN INGENANE COMPOUND FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF CANCER
DE69624072D1 (en) The disposable protective mask
DE69510024D1 (en) syringe
IS4698A (en) inhaler
NO306235B1 (en) Use of a drug for the treatment of arthritis
DK0830166T3 (en) inhaler
PT777457E (en) THE USE OF GLYCERYL TRIACETATE FOR THE TREATMENT OF ONICOMICOSES
NO975660D0 (en) Use of benzimidazoles for the manufacture of a drug for the treatment of liver chemistry
BR9600809A (en) Medication
EE9700168A (en) Bicyclic isothiourea derivatives for therapeutic use
EE03384B1 (en) Use of melatonin for the manufacture of a medicament
DK0866699T3 (en) Use of cholinesterase inhibitors for the manufacture of a medicament for the treatment of xerostomy
DE59610423D1 (en) PARTICULAR MEDICINE
LV11966A (en) Anti-inflammatory medication for use
NO962385D0 (en) Therapeutic amides
KR970003938U (en) Patient Assistance Helmet
KR970020845U (en) Supplementary tape for the treatment of musculoskeletal diseases
ATE239508T1 (en) PARTICULAR MEDICINAL FORM

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20070129